Arix Bioscience PLC | Finanzwire

PRESS RELEASE

published on 11/03/2023 at 17:30, 2 years 4 months ago

PDMR Notification & Director Shareholding
PRESS RELEASE

published on 11/02/2023 at 19:20, 2 years 4 months ago

PDMR Notification & Director Shareholding
PRESS RELEASE

published on 11/01/2023 at 17:30, 2 years 4 months ago

Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
PRESS RELEASE

published on 10/24/2023 at 08:00, 2 years 5 months ago

Portfolio company Harpoon Therapeutics announces up to $150 million private placement
PRESS RELEASE

published on 10/06/2023 at 08:00, 2 years 5 months ago

Unaudited NAV for September 2023
PRESS RELEASE

published on 09/27/2023 at 08:01, 2 years 5 months ago

Interim Results for the Six Months Ended 30 June 2023
PRESS RELEASE

published on 09/27/2023 at 08:00, 2 years 5 months ago

Board Change
PRESS RELEASE

published on 09/14/2023 at 08:01, 2 years 6 months ago

Notice of Results and Investor Presentation
PRESS RELEASE

published on 09/14/2023 at 08:00, 2 years 6 months ago

Unaudited NAV for August 2023
PRESS RELEASE

published on 08/07/2023 at 08:00, 2 years 7 months ago

Unaudited NAV for July 2023

Published on 03/25/2026 at 18:53, 57 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 1 hour 19 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 2 hours 5 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting
Published on 03/25/2026 at 17:45, 2 hours 5 minutes ago

GUILLEMOT CORPORATION: 2025 ANNUAL RESULTS
Published on 03/25/2026 at 17:42, 2 hours 8 minutes ago

2025/2026 Second quarter Sales

News